The clusterin (CLU) gene is genetically associated with Alzheimer's disease (ad), and CLU levels have been shown to positively correlate with regional Aβ deposition in the brain, including in arteries from cerebral amyloid angiopathy (CAA) patients. This evidence concerns the gene CLU and cerebral amyloid angiopathy.